NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Novartis gets EC nod for Enerzair Breezhaler with sensor and app to treat uncontrolled asthma » Novartis

Novartis gets EC nod for Enerzair Breezhaler with sensor and app to treat uncontrolled asthma

NS Medical Devices is using cookies

Novartis has secured EC approval for Enerzair Breezhaler with sensor and app to treat uncontrolled asthma. (Credit: Novartis AG)

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

Beckman Coulter extends diagnostics partnership with MeMed

US Medical gets FDA nod for Canady Helios cold plasma ablation system

Samsung Medison to acquire French ultrasound software company Sonio

CereVasc gets FDA IDE nod for pivotal study of eShunt System in NPH adults

Medtronic’s Symplicity Spyral RDN system approved in China

Recommended Whitepaper